Functional Characterization of Burkholderia pseudomallei Trimeric Autotransporters by Campos, Cristine G. et al.
Functional Characterization of Burkholderia pseudomallei Trimeric
Autotransporters
Cristine G. Campos, Matthew S. Byrd, Peggy A. Cotter
Department of Microbiology and Immunology, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA
Burkholderia pseudomallei is a tier 1 select agent and the causative agent of melioidosis, a severe and often fatal disease with
symptoms ranging from acute pneumonia and septic shock to a chronic infection characterized by abscess formation in the
lungs, liver, and spleen. Autotransporters (ATs) are exoproteins belonging to the type V secretion system family, with many
playing roles in pathogenesis. The genome of B. pseudomallei strain 1026b encodes nine putative trimeric AT proteins, of which
only four have been described. Using a bioinformatic approach, we annotated putative domains within each trimeric AT protein,
excluding the well-studied BimA protein, and found short repeated sequences unique to Burkholderia species, as well as an unex-
pectedly large proportion of ATs with extended signal peptide regions (ESPRs). To characterize the role of trimeric ATs in patho-
genesis, we constructed disruption or deletion mutations in each of eight AT-encoding genes and evaluated the resulting strains
for adherence to, invasion of, and plaque formation in A549 cells. The majority of the ATs (and/or the proteins encoded down-
stream) contributed to adherence to and efficient invasion of A549 cells. Using a BALB/c mouse model of infection, we deter-
mined the contributions of each AT to bacterial burdens in the lungs, liver, and spleen. At 48 h postinoculation, only one strain,
Bp340::pDbpaC, demonstrated a defect in dissemination and/or survival in the liver, indicating that BpaC is required for wild-
type virulence in this model.
Burkholderia pseudomallei is a Gram-negative soil saprotrophand the causative agent of melioidosis, a severe and often sys-
temic infection that can occur in both chronic and acute forms (1,
2). Acute pulmonary melioidosis is characterized by high fever,
respiratory distress, and the formation of visceral abscesses, while
chronic pulmonary melioidosis is characterized by prolonged
pneumonia and abscess formation in the lungs, liver, and spleen
(2). Overall mortality due to melioidosis is high, approaching 50%
in Thailand and 20% in Australia (2, 3). B. pseudomallei is en-
demic to Southeast Asia and northern Australia but has also been
identified in Africa, South and Central America, India, and the
Middle East (4, 5). Intrinsic resistance to clinically important
antibiotics, including beta-lactams and many macrolides and
aminoglycosides (6, 7), as well as the ability to invade and persist
in phagocytic cells (8, 9), contributes to the difficulty in success-
fully treating B. pseudomallei infections. Intense antibiotic therapy
over several months is often required to eliminate this bacterium,
but despite a robust treatment regimen, relapse occurs at a high
frequency (10).
B. pseudomallei is able to adhere to and invade a variety of
epithelial cell lines and has also been shown to invade and survive
within macrophage-like cells (8, 11–14). Following uptake by a
eukaryotic cell, B. pseudomallei is able to escape the endocytic
compartment and enter the cytoplasm by using one of its type III
secretion systems (T3SS). Once in the cytoplasm, the bacterium
polymerizes host actin using the surface protein BimA to move
within host cells, avoiding exposure to the extracellular space (9,
15). B. pseudomallei can induce fusion of neighboring host cell
membranes, leading to the formation of multinucleated giant cells
(MNGC), in a process that depends on one of its type VI secretion
systems (T6SS) (9, 16–18). Although several putative B. pseu-
domallei adhesins have been identified by genomic screens and
protein microarrays (19, 20), only a few have been characterized,
including type IV pili and two putative autotransporter (AT) pro-
teins, BoaA and BoaB (21, 22).
AT proteins, the largest family of secreted proteins among
Gram-negative bacteria, are secreted via the type V secretion sys-
tem pathway. AT proteins share three common features: an N-ter-
minal signal sequence for Sec-dependent translocation into the
periplasm, a central passenger region containing the functional
domain(s), and a highly conserved, outer membrane channel-
forming -barrel at the C terminus that is required for export of
the passenger domain to the surface (23). The two subfamilies of
AT proteins, classical and trimeric, are distinguished by the mech-
anism of -barrel assembly and by the processing and localization
of the passenger domain (24). The C-terminal -domains of clas-
sical ATs are sufficient to form a channel, while trimeric ATs re-
quire three polypeptides to form the outer membrane channel,
with each -domain contributing one-third of the channel (23,
25, 26). In addition, classical AT proteins function as monomers,
and cleavage of the passenger domain usually occurs at or near the
junction of the -barrel and passenger domains. Once cleaved,
classical ATs remain noncovalently associated with the cell surface
or are released into the extracellular environment (23, 24). In con-
trast, trimeric AT passenger domains remain covalently linked to
the -domain, with the N terminus located distal to the cell sur-
face (23, 25).
AT proteins have been implicated in virulence in numerous
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Gram-negative bacterial pathogens. Two prototypical trimeric
ATs, YadA (from Yersinia enterocolitica) and Hia (from Haemo-
philus influenzae), function as adhesins, and YadA also confers
serum resistance by interfering with complement activation (27,
28). B. pseudomallei strain 1026b, isolated from a melioidosis pa-
tient in Thailand (29), carries 11 putative AT proteins (2 classical
and 9 trimeric proteins). Homologs of the AT-encoding genes
have been identified in strain K92643 and are generally well con-
served among other B. pseudomallei isolates (30). Apart from the
host-actin-polymerizing BimA protein, only three B. pseudomallei
trimeric AT proteins have been described. BoaA and BoaB have
been reported to function as adhesins in vitro and to contribute to
B. pseudomallei replication inside macrophage-like cells (21). A
portion of the passenger domain of a third AT protein, encoded by
bpaA, has been crystallized, and the structure of its tightly woven
trimeric head region resembles that of other trimeric ATs, includ-
ing YadA, Hia, and BadA from Bartonella henselae (31).
In this study, we investigated eight B. pseudomallei trimeric
ATs and evaluated their roles in adherence, invasion, and plaque
formation in vitro. We also performed the first animal experi-
ments using any B. pseudomallei strains defective for production
of trimeric ATs and found that one trimeric AT, BpaC, is required
for efficient dissemination of bacteria to or survival within the
liver in a BALB/c mouse respiratory infection model.
MATERIALS AND METHODS
Bacterial strains. All manipulations of B. pseudomallei were conducted in
a CDC/USDA-approved animal biosafety level 3 (ABSL3) facility at the
University of North Carolina at Chapel Hill. The bacterial strains used in
this study are listed in Table 1. B. pseudomallei strains were cultured in
low-salt lysogeny broth (LSLB; 10 g/liter tryptone, 5 g/liter yeast extract,
2.5 g/liter NaCl) or on LSLB agar (Sigma-Aldrich, St. Louis, MO) for 24 h
at 37°C. Escherichia coli strains were grown in LB (10 g/liter tryptone, 5
g/liter yeast extract, 10 g/liter NaCl) or on LB agar. Where appropriate,
culture media were supplemented with kanamycin (Km; 125 g/ml for B.
pseudomallei and 50 g/ml for E. coli). LB agar was supplemented with 400
g/ml of diaminopimelic acid (DAP; LL-, DD-, and meso-isomers; Sigma-
Aldrich, St. Louis, MO) to support growth of RHO3 cells (32). Yeast
extract-tryptone (YT; 10 g/liter of yeast extract and 10 g/liter of tryptone)
medium supplemented with 15% sucrose and X-Gluc (5-bromo-4-
chloro-3-indolyl--D-glucuronic acid; GoldBio, St. Louis, MO) was used
for counterselection during the construction of B. pseudomallei deletion
mutant strains (32).
Construction of B. pseudomallei mutant strains and plasmids. De-
letion of the boaB, bpaE, bpaF, and baaFG genes from B. pseudomallei
strain Bp340 (a derivative of strain 1026b containing a amrRAB-oprA
mutation [33]) was carried out by allelic exchange using pEXKm5 deriv-
atives (32). DNA fragments containing approximately 500 bp 5= of the
gene(s) (including the first three codons) and 500 bp 3= of the gene(s)
(including the last three codons) were generated using a two-step, overlap
PCR approach or were cloned directly into pEXKm5, resulting in plas-
TABLE 1 Strains and plasmids used in this study
Strain or plasmid Description Source or reference
Strains
E. coli strains
DH5 Molecular cloning strain 67
RHO3 Conjugation strain; Kms asd aphA 32
B. pseudomallei strains
Bp340 amrRAB-oprA derivative of B. pseudomallei 1026b 33
Bp340::pDboaA Bp340 with boaA disrupted by pCC1; Kmr This study
Bp340::pDboaB Bp340 with boaB disrupted by pCC2; Kmr This study
Bp340::pDbpaA Bp340 with bpaA disrupted by pCC3; Kmr This study
Bp340::pDbpaB Bp340 with bpaB disrupted by pCC4; Kmr This study
Bp340::pDbpaC Bp340 with bpaC disrupted by pCC5; Kmr This study
Bp340::pDbpaD Bp340 with bpaD disrupted by pCC6; Kmr This study
Bp340::pDbpaE Bp340 with bpaE disrupted by pCC7; Kmr This study
Bp340::pDbaaE Bp340 with baaE disrupted by pCC7; Kmr This study
Bp340::pDbpaF Bp340 with bpaE disrupted by pCC8; Kmr This study
Bp340 boaB Bp340 with an in-frame, nonpolar boaB deletion This study
Bp340 bpaE Bp340 with an in-frame, nonpolar bpaE deletion This study
Bp340 bpaF Bp340 with an in-frame, nonpolar bpaF deletion This study
Bp340 baaFG Bp340 with an in-frame, nonpolar baaFG deletion This study
Plasmids
pEXKm5 Allelic exchange vector; Apr Kmr sacB gusA 32
pCC1 pCC with a 420-bp internal fragment of boaA; Kmr This study
pCC2 pCC with a 409-bp internal fragment of boaB; Kmr This study
pCC3 pCC with a 411-bp internal fragment of bpaA; Kmr This study
pCC4 pCC with a 419-bp internal fragment of bpaB; Kmr This study
pCC5 pCC with a 396-bp internal fragment of bpaC; Kmr This study
pCC6 pCC with a 1,716-bp internal fragment of bpaD; Kmr This study
pCC7 pCC with a 434-bp internal fragment of bpaE; Kmr This study
pCCbaaE pCC with a 370-bp internal fragment of baaE; Kmr This study
pCC8 pCC with a 684-bp internal fragment of bpaF; Kmr This study
pCCX3 pEXKm5 with bpaE flanking sequences; Apr Kmr This study
pMBX1 pEXKm5 with bpaF flanking sequences; Apr Kmr This study
pMBX2 pEXKm5 with baaFG flanking sequences; Apr Kmr This study
pMBX3 pEXKm5 with boaB flanking sequences; Apr Kmr This study
Trimeric Autotransporters in B. pseudomallei Virulence
August 2013 Volume 81 Number 8 iai.asm.org 2789
mids pMBX3, pCCX3, pMBX1, and pMBX2. Plasmids were transformed
into E. coli RHO3 cells and delivered to Bp340 by conjugation (32). Dis-
ruption strains were constructed by amplifying an internal fragment
within each gene and ligating this fragment into the suicide vector pCC (a
derivative of pRE118 [34] created by digesting the plasmid with EcoRI and
religating the backbone without the sacB1 gene). Plasmids were trans-
formed into E. coli RHO3 cells and were delivered to Bp340 by conjuga-
tion. Primer sequences are provided in Table S1 in the supplemental ma-
terial, and plasmid construction is also described in detail in the
supplemental material.
Bacterial conjugations. Matings between B. pseudomallei and E. coli
strain RHO3 were performed by incubating Bp340 with RHO3 cells car-
rying the appropriate allelic exchange plasmid or disruption plasmid (Ta-
ble 1) on LSLB-DAP agar plates overnight. Cointegrants were selected on
LSLB containing Km (LSLB/Km). For deletion strains, cointegrants con-
firmed for plasmid insertion by PCR were grown overnight in LSLB with-
out selection, allowing for a second recombination event to occur and for
the plasmid to be lost. An aliquot of cells was plated on YT agar supple-
mented with 15% sucrose and X-Gluc, as previously described (32). Col-
onies arising from the counterselection were screened by PCR for the
deletion mutation and/or disruption mutation, and all strains were con-
firmed by DNA sequencing.
Plasmid stability in vitro. Strains containing plasmid disruption mu-
tations were grown overnight on LSLB plates containing Km, and single
colonies were picked and grown in 10 ml LSLB without Km for 48 h at
37°C. At 24 h and 48 h, an aliquot from each culture was diluted to an
optical density at 600 nm (OD600) of 0.1, and serial dilutions were plated
on LSLB plates with and without Km. Plasmid loss was calculated from the
difference in the numbers of colonies on LSLB compared to LSLB/Km.
Experiments were performed in triplicate.
Plaque assay. B. pseudomallei strains were grown overnight in LSLB at
37°C. Each well of a 6-well plate was seeded with A549 human lung epi-
thelial cells such that confluent monolayers contained approximately 1 
106 cells per well. Cells were incubated in F12K medium (Cellgro, Circle
Westwood, MA) supplemented with 10% fetal bovine serum (FBS; Gibco,
Grand Island, NY) at 37°C with 5% CO2. Bacterial suspensions were di-
luted to an OD600 of 0.1 in fresh tissue culture medium and then further
diluted 1:10, and 25 l of the diluted culture was added to each well
(multiplicity of infection [MOI] of 0.1) (35). Plates were incubated for 2 h,
and each well was washed thoroughly with fresh culture medium and
overlaid with a mixture containing 1.2% low-melting-point agarose
(Fisher Scientific, Fairlawn, NJ), F12K with 10% FBS, gentamicin (Gm; 90
g/ml), and 0.01% neutral red (Fisher Scientific, Waltham, MA). Plates
were incubated for 24 h at 37°C with 5% CO2, and the plaques in each well
were enumerated.
Adherence and invasion assays. Bacterial strains and A549 cells were
grown as described above. Bacteria were diluted to an OD600 of 0.1 in fresh
tissue culture medium, and 250 l of the diluted culture was added to each
well of a 6-well plate (MOI of 100) (36). Plates were incubated for 2 h, and
each well was washed thoroughly with fresh culture medium. For the
adherence assay, cells were immediately lysed using 1% Triton X-100
(Sigma-Aldrich, St. Louis, MO), and lysates were diluted and plated to
determine the total number of CFU in each well. For the invasion assay,
cells were incubated for an additional 90 min in the presence of Gm (90
g/ml), washed with fresh culture medium, and lysed using 1% Triton
X-100. Lysates were diluted and plated to determine the total number of
CFU in each well. To calculate the percentage of adherent or internalized
bacteria, the number of adherent or internalized bacteria was divided by
the total number of bacteria in the inoculum and multiplied by 100.
Animal experiments. All animal experiments were approved by the
Animal Studies Committee of the University of North Carolina at Chapel
Hill (protocol 10-165). Six- to 8-week-old female BALB/c mice (The Jack-
son Laboratory, Bar Harbor, ME) were allowed free access to sterilized
food and water. Animals were anesthetized with Avertin (140 mg/kg of
body weight; Sigma-Aldrich, St. Louis, MO) by intraperitoneal injection
prior to infection. For all infections, the desired inoculum of B. pseu-
domallei was suspended in phosphate-buffered saline (PBS). Mice were
inoculated intranasally with 500 CFU of B. pseudomallei and were eutha-
nized by CO2 overdose at the indicated time points. At least three animals
per strain were infected, and some experiments were performed twice and
the results combined. Animal experiments were terminated at 48 h, at
which time all animals had become moribund. Organs were aseptically
harvested and homogenized, and the bacterial burden in each organ was
determined by plating serial dilutions of the homogenates.
RESULTS
Bioinformatic characterization of putative trimeric AT-encod-
ing gene loci. Nine putative trimeric AT-encoding genes were
identified in the genome of the B. pseudomallei clinical isolate
1026b, based on sequences at the 3= ends of the open reading
frames (ORFs) that are predicted to encode the characteristic
-domain. The trimeric AT-encoding gene bimA, which has been
characterized extensively (15, 35), was not included in our analy-
sis. Three of the remaining eight genes were annotated previously,
as follows: boaA (for Burkholderia oligomeric coiled-coil adhesin
A), boaB (21), and bpaA (for Burkholderia pseudomallei auto-
transporter A) (31). For simplicity, we named the remaining five
uncharacterized genes bpaB to -F. The trimeric AT-encoding
genes are distributed between the two B. pseudomallei chromo-
somes: boaB, bpaB, and bpaC are on chromosome I, while boaA,
bpaA, and bpaD to -F are on chromosome II (Fig. 1).
One or more additional ORFs with unknown functions are
present 3= of and in the same orientation as four of the predicted
AT genes (bpaA, bpaB, bpaE, and bpaF) (Fig. 1). The
BP1026B_II1528 ORF, located 3= of bpaA, is predicted to encode a
protein containing the consensus N-terminal lipobox sequence
LAGC but lacking a Lol avoidance signal necessary for retention at
the inner membrane, suggesting that this protein is a lipoprotein
that is localized to the inner leaflet of the outer membrane (37, 38).
The ORFs 3= of bpaB and bpaE (BP1026B_I2045 or baaB
[for Burkholderia autotransporter-associated protein B] and
BP1026B_II0997 or baaE, respectively) are predicted to encode
OmpA family proteins that share 29% amino acid sequence iden-
tity. Like the BP1026B_II1528 gene product, the proteins encoded
by baaB and baaE possess lipobox sequences (LGAC and LTGC,
respectively) and are likely localized to the inner leaflet of the outer
membrane, given the lack of a Lol avoidance signal. Immediately
3= of bpaF is an ORF (BP1026B_II1531) that encodes a hypothet-
ical protein containing domain of unknown function 2827
(DUF2827). DUF2827 proteins are well conserved among Burk-
holderia species, and though a second DUF2827 protein-encoding
ORF (BP1026B_II1532) immediately follows the first, the two
proteins share only 48% amino acid sequence identity. To distin-
guish these DUF2827 protein-encoding genes in later analyses, we
refer to them as baaF and baaG.
The first fully sequenced B. pseudomallei strain, K92643, was
isolated from a patient in Thailand and is the strain in which the 11
autotransporter-encoding genes were first identified (21, 30, 39,
40). Although genes predicted to encode trimeric ATs are con-
served among B. pseudomallei strains, two of the eight putative
AT-encoding genes in our study are annotated differently in strain
1026b compared to K92643. boaA (BPSS0796 in K92643) is unan-
notated in the 1026b genome, but an alignment of the region
expected to contain boaA with the corresponding region of the
K92643 genome shows that boaA is indeed present in 1026b and is
91.5% identical to BPSS0796 at the nucleotide level. Similarly,
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bpaD (BPSS0088 in K92643) is annotated as a pseudogene of 1,833
bp in 1026b; however, aligning the nucleotide sequence 5= of bpaD
with that of BPSS0088 reveals a full-length bpaD gene that is
84.6% identical to BPSS0088 at the nucleotide level.
Bioinformatic characterization of putative trimeric AT pro-
teins. The predicted proteins encoded by boaA, boaB, and bpaA to
-F range in size from 72.3 kDa (BpaD; 782 amino acids [aa]) to
241.5 kDa (BpaA; 2,575 aa) and share features common to all
trimeric ATs, including a 70- to 80-aa C-terminal -barrel do-
main and a passenger domain containing numerous short re-
peated sequences (Fig. 2). Interestingly, seven of the eight trimeric
AT proteins (all but BpaD) have a well-conserved 23-aa extended
signal peptide region (ESPR) (black regions in Fig. 2) preceding a
typical N-terminal signal sequence (dark blue regions in Fig. 2);
FIG 1 B. pseudomallei 1026b putative trimeric AT gene loci. The genomic context of each putative trimeric AT gene is drawn to scale, with the predicted function
of immediate 3= genes indicated, if present. The chromosome on which each trimeric AT gene is present is indicated (I or II).
FIG 2 B. pseudomallei 1026b putative trimeric AT protein domains. Domains predicted by daTAA (domain annotation of trimeric autotransporter adhesins) are
indicated in the legend. The characteristic C-terminal -barrel domain is shown in yellow, and predicted coiled-coil regions are underlined. White regions are
sequences with limited homology to known AT proteins, and in BoaA, BoaB, BpaA, BpaB, and BpaF, they contain repeats of 11 (SLSTSTSTGTG), 14 [SLSTG
LSTTNS(N/T/S)(V/L)(A/T)], and 18 [SLSTSTSTGLSSA(N/T/Q)SS(I/V)A] amino acids.
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these regions begin with the sequence MN(K/R) and resemble the
ESPRs of other trimeric AT and two-partner secretion proteins
(Fig. 3). ESPRs can be found in 10% of ATs and may be involved
in regulating the translocation of ATs across the inner membrane
into the periplasm (23, 41). Although BpaD as annotated does not
contain an ESPR, manually translating the sequence immediately
5= of the bpaD ORF reveals codons for an MNR consensus se-
quence beginning 14 amino acids N-terminal to the predicted
valine start codon. However, between the MNR and initial valine
codons are two UGA stop codons, preventing the ESPR-like re-
gion from being translated. Therefore, it appears that BpaD,
which is predicted to be the smallest of the trimeric ATs in B.
pseudomallei, may have had an ESPR earlier in its evolutionary
history (Fig. 3).
We used the domain annotation of trimeric autotransporter
adhesins (daTAA) software to predict motifs within the passenger
domains of B. pseudomallei trimeric AT proteins that have been
described previously for other trimeric ATs (42). One particular
repeated sequence, the YadA-like head motif (also known as the
NSVAIG-S motif), is present in all eight proteins, making up the
majority of the passenger domains of BpaC and BpaD (Fig. 2).
This motif has been implicated in YadA-dependent collagen bind-
ing in Yersinia enterocolitica, though its role in B. pseudomallei
adherence and/or virulence has not been assessed (43).
Five of the putative trimeric AT proteins (BoaA, BoaB, BpaA,
BpaB, and BpaF) possess repeat regions in the passenger domain
that are not common outside Burkholderia species and that share
the N-terminal amino acid sequence SLST. These repeats are 11,
14, and 18 amino acids long, with consensus sequences of SLSTS
TSTGTG, SLSTGLSTTNS(N/T/S)(V/L)(A/T), and SLSTSTSTGL
SSA(N/T/Q)SS(I/V)A, respectively. A large portion of the passen-
ger domains of BoaA and BoaB and nearly the entire passenger
domains of BpaA and BpaF are composed of SLST repeats; how-
ever, searches for both primary amino acid sequence and second-
ary structure homologies fail to suggest a structure or function for
these repeats. In strain 1026b, BoaA and BoaB are 63.1% identical
and share similarly annotated regions within their passenger do-
mains, perhaps suggesting that BoaA and BoaB are the result of a
gene duplication event.
Construction of mutant strains. To evaluate the contribu-
tions of putative trimeric ATs to B. pseudomallei virulence, we
constructed strains containing plasmid disruption and/or dele-
tion mutations in each AT-encoding gene, as well as in the ORF(s)
3= of two AT-encoding gene loci (Fig. 4). Plasmid disruptions were
made such that the suicide plasmid pCC carrying an internal frag-
ment of the AT-encoding gene (or of the gene 3= of bpaE) inte-
grated at approximately the midpoint of the coding region of each
gene via single-crossover homologous recombination. The pres-
ence of nptII (encoding a Km resistance protein) on the plasmid
allowed for selection of cointegrants, and plating the strains on
selective and nonselective media provided a means to assess the
presence of the plasmid.
To test the stability of chromosomal integration of the disrup-
tion plasmids, we grew the disruption mutation strains in LSLB
without Km and determined the percentage of cells that had re-
tained (Kmr) or lost (Kms) the plasmid after 48 h of incubation at
37°C. There was no significant plasmid loss for seven of eight
AT-encoding gene disruption mutants or for Bp340::pDbaaE (Ta-
ble 2). However, nearly all (97%) Bp340::pDboaB cells had lost the
plasmid after 24 h, suggesting that either the truncated BoaB=
polypeptide interferes with growth in vitro or the plasmid is simply
unstable in this location.
Because the plasmid instability observed for Bp340::pDboaB
prevented the use of this strain in subsequent assays, we con-
structed an unmarked, in-frame deletion mutation of boaB by
using the allelic exchange plasmid pEXKm5, which has been used
previously in Burkholderia spp. (32). We also created strains with
in-frame deletion mutations in bpaE, bpaF, and a region encom-
passing both genes 3= of bpaF (Fig. 4). We chose to delete the two
genes 3= of bpaF due to their unique presence in Burkholderia and
their predicted function as glycosyltransferase genes, as glycosyla-
tion is a critical posttranslational modification of certain ATs (44).
One B. pseudomallei trimeric AT, BpaE, contributes to
plaque formation in A549 cells. B. pseudomallei can spread from
cell to cell without exiting the cytoplasm and can form plaques in
a cell monolayer (35, 45, 46). In vitro, this process can be quanti-
fied by assessing the ability of B. pseudomallei to form plaques in a
monolayer of cultured cells. We evaluated strains containing dis-
ruption mutations in seven of the eight putative trimeric AT-en-
coding genes (all but boaB) for plaque formation compared to that
of the wild-type strain, Bp340 (Fig. 5A). Six of the seven disruption
mutants formed plaques at a frequency similar to that of Bp340,
which formed approximately 75 plaques per well. Bp340::pDbpaE,
however, formed significantly fewer plaques than Bp340 (15.5 
3.26 compared to 78.5  4.39; P 	 0.01). We likewise evaluated
plaque formation by the boaB deletion mutant but did not observe
a difference compared to that by Bp340 (Fig. 5B). Our results
suggest that BpaE and/or the OmpA family protein encoded by
FIG 3 ESPRs of putative B. pseudomallei 1026b trimeric AT proteins. Extended signal peptides and conventional signal peptides are indicated. N1, N-terminal
charged region of the ESPR; H1, C-terminal hydrophobic region of the ESPR; N2, N-terminal charged region of the conventional signal peptide; H2, central
hydrophobic region of the conventional signal peptide; C, signal peptidase recognition site, with putative cleavage site indicated with a hyphen. The N1, H1, N2,
H2, and C regions were defined as described previously (41). For BpaD, “V” indicates the predicted start codon.
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baaE is required for one or more steps in the plaque formation
process, which include adherence, invasion, intracellular survival,
and cell-cell fusion.
All trimeric ATs tested, except BpaF, contribute to B. pseu-
domallei adherence to A549 cells. The plaques formed by Bp340::
pDbpaE appeared to be similar in size to those formed by Bp340,
suggesting that bpaE and/or baaE might be involved in plaque
formation at a step prior to cell-cell fusion. We evaluated all seven
disruption mutants and Bp340 boaB for adherence to A549 cells
as described in Materials and Methods. We plated the A549 cell
lysates on LSLB agar without Km selection to determine the total
number of adherent bacteria and on LSLB/Km agar to determine
the number of adherent bacteria that still contained the cointe-
grated plasmid. For all disruption mutants, the number of Kmr
CFU recovered was lower than the total number of CFU recov-
ered, and the difference was especially dramatic for Bp340::
pDbpaC, Bp340::pDbpaE, and Bp340::pDbpaF (Fig. 6A). Com-
pared with the approximately 95% retention of the plasmid after
24 h of growth in vitro, these data indicate a strong selection for
bacteria that had lost the plasmid via homologous recombination
(hence reverting to the wild type) in the assay. In all cases except
Bp340::pDbpaF, the number of Kmr (i.e., mutant) CFU recovered
from the A549 cells was significantly decreased compared to that
FIG 4 Schematic of deletion and disruption mutations used in this study.
TABLE 2 Disruption of plasmid stability in vitro
Strain
% Plasmid lossa
24 h 48 h
Bp340::pCC1 3.33  0.43 5.62  1.03
Bp340::pCC2 97.03  0.82 ND
Bp340::pCC3 2.47  0.56 2.75  0.56
Bp340::pCC4 4.65  0.11 8.76  0.57
Bp340::pCC5 2.06  0.93 5.02  1.41
Bp340::pCC6 1.03  0.49 0.90  1.79
Bp340::pCC7 1.12  0.51 3.63  0.20
Bp340::pCCbaaE 
0.052  1.52 2.24  1.17
Bp340::pCC8 3.20  1.40 7.23  0.72
a Percent plasmid loss after growth in LSLB without selection for the indicated period.
ND, not done.
FIG 5 Plaque formation by B. pseudomallei 1026b trimeric AT disruption
mutants. A549 cells (approximately 1  106 cells per well in a 6-well plate)
were inoculated with B. pseudomallei trimeric AT disruption mutants at an
MOI of 0.1, and plates were incubated for 2 h at 37°C. Plates were washed
thoroughly with fresh medium and were overlaid with a mixture containing
F12K medium, low-melting-point agarose, gentamicin, and neutral red. Plates
were incubated for 24 h at 37°C with 5% CO2, and plaques in each well were
enumerated. Data are means  standard errors of the means (SEM) for two
sets of experiments (A and B) performed in triplicate. Significance of differ-
ences was determined relative to Bp340. **, P 	 0.01 by Tukey’s multiple-
comparison test following one-way analysis of variance (ANOVA).
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of Bp340. The number of CFU recovered for Bp340 boaB was
also significantly lower than that of the wild type (Fig. 6B). Taken
together, our data suggest that all of the trimeric ATs tested and/
or, in some cases, proteins encoded downstream, except BpaF,
contribute to adherence to A549 cells.
All trimeric ATs tested, except BoaB, contribute to efficient
internalization in A549 cells. Some trimeric AT proteins are
known to be multifunctional, including Proteus mirabilis AipA
and Yersinia pseudotuberculosis YadA, both of which function as
adhesins and mediate entry into eukaryotic cells (47–49). To ad-
dress the contribution of B. pseudomallei 1026b trimeric ATs to
A549 cell internalization, we performed invasion assays with the
seven disruption mutants and the boaB deletion mutant. Similar
to the adherence assay results, the number of Kmr CFU recovered
for each disruption mutant was lower (especially for Bp340::
pDboaA, Bp340::pDbpaB, and Bp340::pDbpaD) than the total
number of CFU recovered, despite the stable integration of the
plasmids observed in vitro (Fig. 6C and Table 2). Compared to
Bp340, all seven disruption mutants were significantly attenuated
in the ability to invade A549 cells, a phenotype at least somewhat
due to internalization requiring initial bacterial adherence (Fig.
6C). Two of the strains severely deficient in internalization, i.e.,
Bp340::pDbpaE and Bp340::pDbpaF, displayed milder pheno-
types in the adherence assay, suggesting that BpaE and BpaF (or
the gene products encoded immediately 3= of bpaE and bpaF) may
promote internalization apart from their apparent function as ad-
hesins. The one deletion strain tested, Bp340 boaB, was recov-
ered at a level similar to that of Bp340 (Fig. 6D).
Evaluation of B. pseudomallei trimeric ATs in a mouse
model of acute infection. The B. pseudomallei trimeric AT pro-
teins BoaA and BoaB have been implicated in adherence to and
invasion of host cells (21) (Fig. 6), but there has been no charac-
FIG 6 Contributions of trimeric AT proteins to adherence and invasion. A549 cells were grown as described for plaque formation experiments and were
inoculated with the indicated strains at an MOI of 100. Plates were incubated for 2 h, and each well was washed thoroughly with fresh culture medium. For
adherence of the trimeric AT disruption mutants (A) and Bp340 boaB (B), cells were immediately lysed using 1% Triton X-100, and lysates were diluted and
plated to determine the total number of CFU. For invasion of the trimeric AT disruption mutants (C) and Bp340 boaB (D), cells were incubated for an
additional 90 min in the presence of gentamicin, washed with fresh culture medium, and lysed using 1% Triton X-100. Lysates were diluted and plated to
determine the total number of CFU. For both assays, lysates were plated on LSLB and LSLB containing Km to assess plasmid loss. Data are means  SEM for
percentages of adherent or internalized bacteria compared to the inoculum and represent two experiments performed in triplicate. Significance of differences was
determined relative to Bp340. *, P 	 0.05; **, P 	 0.01; ***, P 	 0.001 by Tukey’s multiple-comparison test following one-way ANOVA.
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terization of BoaA, BoaB, or BpaA to -F in an animal model of B.
pseudomallei infection. We hypothesized that one or more trim-
eric ATs would be required for B. pseudomallei virulence, consis-
tent with the role of other trimeric ATs in virulence in a variety of
Gram-negative pathogens (49–53). We infected BALB/c mice in-
tranasally with 500 CFU of Bp340 or the trimeric AT-encoding
gene disruption or deletion strains and then sacrificed the mice at
48 h postinoculation and determined bacterial burdens in the
lungs, liver, and spleen. Mutants with plasmid disruptions of tri-
meric AT genes were plated on both LSLB and LSLB with 125
g/ml Km to assess plasmid loss in vivo.
At 48 h, the lungs of mice infected with Bp340 contained ap-
proximately 106 to 108 CFU, while the liver and spleen contained
approximately 105 to 106 CFU of B. pseudomallei (Fig. 7). There
was no significant difference in bacterial burden in any of the three
organs for Bp340::pDboaA and Bp340 boaB compared to Bp340
(Fig. 7A and B). Likewise, the burdens of Bp340::pDbpaA, Bp340::
pDbpaB, and Bp340::pDbpaD were not different from that of
Bp340 in any of the organs (Fig. 7C, D, and F). Although the
burden of Bp340::pDbpaC was not different from that of Bp340
when cells were plated on LSLB in the absence of selection, there
was significant plasmid loss in the liver, suggesting that this strain
was defective in the ability to disseminate to or survive in this
organ (Fig. 7). We did not observe any plasmid loss in the other
disruption mutant strains, suggesting that there was a lack of se-
lective pressure to have intact trimeric AT-encoding genes or any
immediately 3= ORFs in this environment. At the time of sacrifice,
all animals were moribund, regardless of infecting strain, indicat-
ing that the 50% lethal dose (LD50) for each mutant strain was
similar to that for Bp340 and less than the inoculum of 500 CFU.
To account for possible polar effects on the gene(s) 3= of bpaE
and bpaF due to plasmid disruption of the trimeric AT-encoding
FIG 7 Contributions of B. pseudomallei 1026b trimeric ATs to virulence in vivo. Six- to 8-week-old female BALB/c mice were anesthetized with Avertin by
intraperitoneal injection and were inoculated intranasally with 500 CFU of B. pseudomallei trimeric AT disruption (A, C, and D to F) and deletion (B and G to
I) mutation strains. Mice were euthanized by CO2 overdose at the indicated time points, and the lungs, liver, and spleen were aseptically harvested and
homogenized. For each organ, the bacterial burden was determined by plating serial dilutions of the homogenates. For disruption mutants (A, C, and D to F),
homogenates were plated on both LSLB and LSLB containing Km to assess plasmid loss. Significance of differences was determined relative to Bp340. **, P 	 0.01;
***, P 	 0.001 by Tukey’s multiple-comparison test following one-way ANOVA.
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genes, we constructed in-frame deletion mutations in bpaE and
bpaF, in anticipation that one or both encoded ATs would con-
tribute to B. pseudomallei pathogenesis. We also constructed a
strain with a disruption mutation in the gene 3= of bpaE (baaE)
and a strain with an in-frame deletion in the genes 3= of bpaF (baaF
and baaG). Both Bp340 bpaE and Bp340 bpaF were able to
establish infection in the lung and to disseminate to the liver and
spleen, similar to Bp340 (Fig. 7G and H). Additionally, neither
Bp340::pDbaaE nor Bp340 baaFG had a virulence defect (Fig. 7I
and data not shown), suggesting that these highly conserved genes
3= of bpaE and bpaF are not required in the BALB/c intranasal
model of infection.
DISCUSSION
In this study, we identified nine putative trimeric AT-encoding
gene loci in the genome of B. pseudomallei clinical isolate 1026b
and described the predicted domains of eight of the nine corre-
sponding proteins (BimA excluded). We constructed strains
containing disruption and/or deletion mutations in each of the
AT-encoding genes and in genes immediately 3= of certain
AT-encoding genes and then compared them with wild-type B.
pseudomallei for plaque formation, adherence, and internalization
in respiratory epithelial cells. Our characterization of eight trim-
eric ATs revealed that a majority of ATs and/or the proteins en-
coded downstream play a role in adherence to and invasion of
A549 cells. Perhaps surprisingly, only BpaC played a role in viru-
lence in the BALB/c mouse model of B. pseudomallei respiratory
infection.
Nearly all AT proteins characterized so far have been shown to
play roles in pathogenesis in vivo or in virulence-associated assays
(24, 28, 49, 51, 54–56). Protein microarray and expression library
studies have provided evidence that the majority of B. pseudomal-
lei trimeric ATs are produced during human melioidosis (39, 57).
A B. pseudomallei phage library expressed in E. coli revealed five
AT proteins, BoaA, BpaB, BpaE, BpaF, and BimA, that reacted
with convalescent-phase sera from melioidosis patients, indicat-
ing that these proteins were expressed at levels high enough to
elicit an antibody response during infection (39). Additionally, a
protein microarray study of potential antigens serodiagnostic for
B. pseudomallei infection found that BpaA, BpaE, and BimA were
significantly more reactive with melioidosis-positive patient sera
than with melioidosis-negative control sera (57). These studies,
along with the data presented here, support the hypothesis that
most, if not all, trimeric ATs contribute to pathogenesis during
human infection.
The baaB and baaE genes, located 3= of two of the AT-encoding
genes characterized in this study (bpaB and bpaE), are predicted to
encode OmpA family proteins, while the baaA gene, located 3= of
bpaA, encodes a protein of unknown function. All three of these
proteins are predicted to be lipidated and localized to the outer
membrane, suggesting that they may function as accessory pro-
teins for their corresponding ATs (and potentially for other ATs as
well). The requirement of accessory proteins for translocation of
ATs across the periplasm and insertion into the outer membrane
was recently established as a general feature of AT biology (41, 58).
The Bam complex, comprising the integral -barrel protein
BamA and the associated lipoproteins BamBCDE, is necessary for
trimeric AT insertion in the outer membrane, through an un-
known mechanism, while various periplasmic chaperones, such as
SurA, Skp, and DegP, are required for AT passage through the
periplasm (41). Further characterization of the putative accessory
proteins identified in our study will be necessary to determine
their role, if any, in trimeric AT production and function.
Seven of the eight trimeric ATs included in our study possess
ESPRs (Fig. 3). ESPRs were initially thought to function in
cotranslational targeting of large type V family proteins to the
periplasm; however, recent studies suggest that the region serves a
more subtle function, by regulating the rate of translocation across
the inner membrane to avoid an accumulation of misfolded pro-
teins in the periplasm (41, 59, 60). Bioinformatic analyses have
revealed that ESPRs appear to be restricted to type V proteins of
100 kDa in the Beta- and Gammaproteobacteria and are pres-
ent in approximately 10% of AT proteins (23, 24, 41, 61). In B.
pseudomallei 1026b, an uncharacteristically high 78% (seven of
nine) of the trimeric ATs possess ESPRs, and the only two that lack
such a feature are the two smallest trimeric ATs: BpaD and BimA.
However, the fact that BpaD has what appears to be an ESPR
remnant (Fig. 3) leads us to speculate that the ESPR is not neces-
sary to regulate the secretion of proteins of this size and was thus
lost as BpaD evolved.
In addition to the presence of ESPRs in the majority of trimeric
ATs in B. pseudomallei 1026b, five of these proteins contain SLST
repeats of 11, 14, or 18 aa that are unique to Burkholderia species
and have no predicted structure or function. Not surprisingly,
variation in the lengths of BoaA, BoaB, BpaA, BpaB, and BpaF
homologs among B. pseudomallei strains is due largely to different
numbers of SLST repeats in the passenger domain. It is possible,
therefore, that within 1026b, the addition or loss of these repeats is
used by the cell to regulate the length of the passenger domain and
is perhaps related to AT function. Another possibility is that the
serine- and threonine-rich repeats are glycosylation sites. Though
initially thought to be a posttranslational modification restricted
to eukaryotes, protein glycosylation in prokaryotes has been doc-
umented extensively and is important for the function of several
virulence factors, including the classical ATs Ag43 and AIDA-I in
pathogenic E. coli (24, 44, 62, 63). For Ag43, it has been shown that
serine- and threonine-rich regions of the passenger domain are
multiply glycosylated with heptose residues and that the addition
of these sugars is essential for binding to human-derived HEp-2
cells (63). In 1026b, the proteins encoded by baaF and baaG,
which are located immediately 3= of bpaF, have no predicted func-
tion based on homology searches of primary aa sequences, but
structural homology searches revealed the greatest similarity to an
N-acetylglucosamine transferase from the plant pathogen Xan-
thomonas campestris. Although we did not observe a phenotype in
vivo for the mutant lacking both baaF and baaG, we are currently
investigating the glycosylation state of BpaF and other AT proteins
containing SLST repeats, as these genes may be important for AT
function in other models.
In our study, we observed a significant decrease in the number
of plaques formed on an A549 cell monolayer for only one tri-
meric AT-encoding gene disruption strain, Bp340::pDbpaE, com-
pared to the wild-type strain. Though they were rarer, plaques
formed by Bp340::pDbpaE were the same size as those formed by
Bp340, indicating that once bacteria were inside the host cell,
movement between cells was not hindered by loss of bpaE or baaE.
The fact that six of the seven disruption mutants did not show a
plaque formation defect suggests that either these genes are not
important for any step in plaque formation (adherence, invasion,
intracellular survival, and cell-cell fusion) or the disruption plas-
Campos et al.
2796 iai.asm.org Infection and Immunity
mid was lost due to selective pressure to maintain an intact trim-
eric AT-encoding gene. Plasmid loss could occur in the plaque
assay, as it was performed in the absence of Km (Gm was added to
the medium to kill extracellular bacteria, and once inside the A549
cells, Km would be ineffective because it does not cross the cell
membrane). It is difficult to recover bacteria from plaques (espe-
cially in a BSL3 laboratory) to determine the amount of plasmid
loss during the formation of plaques; therefore, we performed
adherence and invasion assays to assess the contributions of trim-
eric ATs to individual steps in the plaque formation process.
Our adherence and invasion assay data suggest that most tri-
meric AT proteins and/or, in some cases, the proteins encoded
downstream contribute to these processes. When bacteria were
grown in vitro without antibiotic selection for 24 h, only approx-
imately 1 to 5% of the bacteria had lost the integrated plasmid. In
the adherence assay used in our study, approximately 4% of the
wild-type B. pseudomallei bacteria adhered to A549 cells within the
2-h incubation period. For most of the mutants, the percent ad-
herent bacteria was below 4%, but the proportion of those that
had lost the plasmid (and hence were genetically identical to
Bp340) was relatively large. These data suggest that the adherence
assay selected for bacteria that had lost the plasmid and therefore
provide strong evidence that the AT proteins and/or the proteins
encoded downstream of them are required for efficient adherence
to and invasion of A549 cells. This conclusion is strengthened by
the fact that in nearly all cases, almost no plasmid loss occurred in
bacteria recovered from the lungs, livers, and spleens of mice that
had been infected for 48 h with the various mutants.
Given the phenotypes displayed by the mutants in the plaque,
adherence, and invasion assays, we expected to observe a role in
pathogenesis for more than one trimeric AT in a BALB/c mouse
model of infection. Instead, our animal experiments revealed a
role only for bpaC in dissemination to or growth in the liver.
Rather than providing a true reflection of the roles of the various
AT proteins in infection, our data may reflect the limitations of the
BALB/c respiratory infection model. Different animal models
have yielded substantially different results with regard to flagella,
one of the few B. pseudomallei virulence factors that has been
examined in detail. DeShazer et al. initially characterized the fliC
gene, encoding the flagellum structural protein, in B. pseudomallei
1026b and reported no difference in virulence for a fliC trans-
poson mutant compared to the wild-type strain in either a diabetic
rat or Syrian hamster model (29). However, they were careful to
note that their results applied only to the two models they tested.
In a more recent study, a fliC mutant strain was evaluated in
BALB/c mice inoculated by the intranasal route, and the mutant
strain was dramatically attenuated for virulence compared to the
wild-type strain, though it did not show a phenotype in an in vitro
cell invasion assay or in the Caenorhabditis elegans model (64).
Even within the same species, the choice of host strain can have
profound consequences on the course of infection with B. pseu-
domallei. A study analyzing B. pseudomallei virulence in two
mouse backgrounds, BALB/c and C57BL/6, found the difference
in 10-day LD50 values between the backgrounds to be nearly 4
orders of magnitude (65). When infected at the same dose, all
BALB/c mice had to be sacrificed after 5 days, whereas all C57BL/6
mice survived until the experiment was terminated at 4 weeks
(65). These observations suggest that comparing our mutant
strains in an expanded number of animal models may reveal roles
for the various AT proteins that cannot be appreciated in BALB/c
mice due to their extreme sensitivity to B. pseudomallei.
Our study is the first to systematically evaluate a class of genes
(those encoding trimeric ATs) in B. pseudomallei both in vitro and
in vivo. While we demonstrated that nearly all ATs tested have a
function in adherence and/or invasion and that BpaC is important
for efficient dissemination to or survival in the liver, we evaluated
only strains in which a single trimeric AT-encoding gene was dis-
rupted or deleted, and our analysis in vivo was limited to a single
animal model and route of infection. It is probable that the dele-
tion or disruption of two, three, or more AT-encoding genes will
result in reduced virulence, and performing such studies would
likely reveal redundant or synergistic functions for some ATs in
infection. Because B. pseudomallei not only infects animals but
also can be found in the rhizosphere, and even within the roots
and foliage of several plant species (66), a full understanding of the
roles of trimeric ATs may require the use of diverse eukaryotic
host models.
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